- Home
- GRWG vs HOWL Comparison
GRWG vs HOWL Comparison
Compare GRWG & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRWG
- HOWL
- Stock Information
- Founded
- GRWG 2008
- HOWL 2017
- Country
- GRWG United States
- HOWL United States
- Employees
- GRWG N/A
- HOWL N/A
- Industry
- GRWG RETAIL: Building Materials
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- GRWG Consumer Discretionary
- HOWL Health Care
- Exchange
- GRWG Nasdaq
- HOWL Nasdaq
- Market Cap
- GRWG 60.6M
- HOWL 50.3M
- IPO Year
- GRWG N/A
- HOWL 2021
- Fundamental
- Price
- GRWG $1.06
- HOWL $1.19
- Analyst Decision
- GRWG Buy
- HOWL Strong Buy
- Analyst Count
- GRWG 4
- HOWL 3
- Target Price
- GRWG $2.38
- HOWL $8.33
- AVG Volume (30 Days)
- GRWG 461.2K
- HOWL 643.1K
- Earning Date
- GRWG 05-08-2025
- HOWL 05-08-2025
- Dividend Yield
- GRWG N/A
- HOWL N/A
- EPS Growth
- GRWG N/A
- HOWL N/A
- EPS
- GRWG N/A
- HOWL N/A
- Revenue
- GRWG $176,681,000.00
- HOWL $1,143,000.00
- Revenue This Year
- GRWG N/A
- HOWL N/A
- Revenue Next Year
- GRWG $0.26
- HOWL $900.00
- P/E Ratio
- GRWG N/A
- HOWL N/A
- Revenue Growth
- GRWG N/A
- HOWL N/A
- 52 Week Low
- GRWG $0.82
- HOWL $0.60
- 52 Week High
- GRWG $2.73
- HOWL $5.73
- Technical
- Relative Strength Index (RSI)
- GRWG 48.06
- HOWL 61.01
- Support Level
- GRWG $1.05
- HOWL $1.18
- Resistance Level
- GRWG $1.16
- HOWL $1.31
- Average True Range (ATR)
- GRWG 0.06
- HOWL 0.11
- MACD
- GRWG -0.01
- HOWL 0.02
- Stochastic Oscillator
- GRWG 23.08
- HOWL 68.83
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.